Alopecia Areata-Part III: Prognosis and Treatment.

Juliany Estefan, Marcia Ribeiro, Eliane Abad, Simone Saintive, Marcia Ramos-E-Silva

Review Skinmed 2016 2 件の引用

<\/script>\n

`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D27871349'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Study Design

研究タイプ: Review
対象集団: alopecia areata patients

介入: Alopecia Areata-Part III: Prognosis and Treatment. None
比較対照: None
主要アウトカム: None
効果の方向: Mixed
バイアスリスク: Unclear

Abstract

The prognosis of alopecia areata is better in cases with single and small lesions, and the variability of the extension of the disease is one of the criteria for the choice of treatment modality. Several medications have been described in the literature for the treatment of alopecia areata, including corticosteroids, minoxidil, and diphencyprone. The authors review treatments for alopecia areata.

要約

The prognosis of alopecia areata is better in cases with single and small lesions, and the variability of the extension of the disease is one of the criteria for the choice of treatment modality.

Used In Evidence Reviews

A ミノキシジル：円形脱毛症

Alopecia Areata-Part III: Prognosis and Treatment.

Embed This Widget

Study Design

Abstract

要約

Used In Evidence Reviews

Similar Papers

Secular trends in dietary intake in the United States.

A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.

The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.

Alopecia areata.

Minoxidil and its use in hair disorders: a review.

Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.